| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.25 | 2e-07 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.23 | 5e-07 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.22 | 8e-05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.088 | 0.06 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.093 | 0.06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.064 | 0.2 |